Tag: Epigenetics

  • Regenerative Medicine Beyond PRP and Stem Cells

    Regenerative Medicine Beyond PRP and Stem Cells

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]

    Published on February 26, 2021

    Dr. Sudhir Diwan discusses regenerative medicine and moving beyond platelet rich plasma (PRP) and stem cells at the NYSIPP/NJSIPP Symposium. He also discusses epigenetics and how these processes relate to pain. Micro RNAs, growth factors, and exosomes may also play a greater role in the future. Stem cells therapy for pain injuries is at an interesting juncture, but only time will tell how they will ultimately be used in the clinic.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]


    [/vc_column_text][/vc_column][/vc_row]

  • Controversies and the Future of Regenerative Medicine

    Controversies and the Future of Regenerative Medicine

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on June 11, 2020

    Dr. Sudhir Diwan provides an extensive overview of the controversies surrounding regenerative medicine and its future in pain medicine. Dr. Diwan lecture includes the use of embryonic and induced pluripotent stem cells, intellectual dishonesty, and “bad actors” who provide unregulated stem cell treatments. He also discusses the role of epigenetics and gene therapy in the future of regenerative medicine, as well as new technologies, such as needle tissue scopes for targeted delivery and nanotechnology.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]


    [/vc_column_text][/vc_column][/vc_row]